Verici DX Plc

About Verici DX Plc

Verici Dx is a company focused on commercializing RNA signature-based tests to provide data-driven insights for clinicians and patients, particularly in the field of kidney transplant technology. Their mission is to deliver personalized patient and organ response risk assessments to improve outcomes through a suite of leading-edge tests. They utilize artificial intelligence-assisted transcriptomic analysis to focus on immune responses and other critical biological signals for transplant prognosis. Additionally, they aim to accelerate innovation through research and collaboration with medical device, biopharmaceutical, and data science partners.

Products & Services

Tutivia™:A test forming part of the kidney transplant platform, focused on personalized risk assessment for transplant patients.

Clarava™:A complementary test in the kidney transplant platform, providing insights into patient and organ response risks.

Protega™:Another test in the kidney transplant suite, aimed at assisting clinicians with data for medical management.

Specialties

RNA Signatures Artificial Intelligence in Diagnostics Kidney Transplant Technology Personalized Medicine Transcriptomic Analysis

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Investment T: - FT: Investment	A: 790000 MR: - FA: £0.79 million FAN: 790000	D: 2025-07-23 FD: 2025-07-23	1 investors
2	RT: Retail Offer T: - FT: Retail Offer	A: 500000 MR: - FA: up to £500,000 FAN: 500000	D: 2025-07-22 FD: 2025-07-22	-

Investment Latest

2025-07-23

$790K

1 investor (Pro only)

Retail Offer 2025-07-22

$500K

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Julian Baines

Non-Executive Chairman

S

Sir Ian Carruthers

Senior Independent Non-Executive Director and chair of the audit committee and nomination committee

S

Sara Barrington

Chief Executive Officer

D

Dr. Erik Lium

Non-Executive Director

J

James McCullough

Non-Executive Director and member of the remuneration committee

D

Dr. Lorenzo Gallon

Nephrologist and Transplant Surgeon

View 17 more team members with Pro

Unlock Full Team Directory

Recent News

Verici DX Plc Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised